Real-life use of lenvatinib in patients with differentiated thyroid cancer: experience from Argentina

被引：0
|
作者：
Fernando Jerkovich
Inés Califano
Fernanda Bueno
Juan Manuel Carrera
Raúl Giglio
Erika Abelleira
Fabián Pitoia
机构：
[1] Universidad de Buenos Aires,División Endocrinología, Hospital de Clínicas “José de San Martín”
[2] Universidad de Buenos Aires,Servicio de Endocrinología, Instituto de Oncología “Ángel H. Roffo”
[3] Universidad de Buenos Aires,Unidad Funcional de Tumores de Cabeza y Cuello, Instituto de Oncología “Ángel H. Roffo”
来源：
Endocrine | 2020年 / 69卷
关键词：
Lenvatinib; Differentiated thyroid cancer; Radioiodine refractoriness; Progression free survival; Tumor response; Adverse events;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：142 / 148
页数：6
相关论文
共 50 条
  • [1] Real-life use of lenvatinib in patients with differentiated thyroid cancer: experience from Argentina
    Jerkovich, Fernando
    Califano, Ines
    Bueno, Fernanda
    Manuel Carrera, Juan
    Giglio, Raul
    Abelleira, Erika
    Pitoia, Fabian
    [J]. ENDOCRINE, 2020, 69 (01) : 142 - 148
  • [2] Ten years' real-life experience on the use of multikinase inhibitors in patients with advanced differentiated thyroid cancer
    Jerkovich, Fernando
    Capalbo, Soledad
    Abelleira, Erika
    Pitoia, Fabian
    [J]. ENDOCRINE, 2024, 85 (02) : 817 - 826
  • [3] Lenvatinib Real-Life Experience
    Markman, Maurie
    [J]. ONCOLOGY, 2019, 97 (04) : 189 - 190
  • [4] Real-life tolerance and plasma exposure assessment of lenvatinib in thyroid metastatic cancer patients
    Goldwirt, L.
    Madelain, V.
    Chougnet, C.
    Benichou, T.
    Sauvageon, H.
    Mourah, S.
    [J]. ANNALS OF ONCOLOGY, 2018, 29
  • [5] Real-life tolerance and plasma exposure assessment of lenvatinib in thyroid metastatic cancer patients
    Goldwirt, L.
    Madelain, V.
    Chougnet, C.
    Benichou, T.
    Sauvageon, H.
    Mourah, S.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2018, 32 : 34 - 34
  • [6] Long-term management of lenvatinib-treated thyroid cancer patients: a real-life experience at a single institution
    Porcelli, Tommaso
    Luongo, Cristina
    Sessa, Francesca
    Klain, Michele
    Masone, Stefania
    Troncone, Giancarlo
    Bellevicine, Claudio
    Schlumberger, Martin
    Salvatore, Domenico
    [J]. ENDOCRINE, 2021, 73 (02) : 358 - 366
  • [7] Long-term management of lenvatinib-treated thyroid cancer patients: a real-life experience at a single institution
    Tommaso Porcelli
    Cristina Luongo
    Francesca Sessa
    Michele Klain
    Stefania Masone
    Giancarlo Troncone
    Claudio Bellevicine
    Martin Schlumberger
    Domenico Salvatore
    [J]. Endocrine, 2021, 73 : 358 - 366
  • [8] Experience of lenvatinib therapy for patients with differentiated thyroid cancer in our hospital
    Miwa, Keisuke
    Fukahori, Masaru
    Tanaka, Toshimitsu
    Nagasu, Sachiko
    Ushijima, Tomoyuki
    Shigetou, Kouta
    Ono, Takeharu
    Umeno, Hirohito
    Torimura, Takuji
    Akagi, Yoshito
    [J]. ANNALS OF ONCOLOGY, 2019, 30
  • [9] Assessment of the efficacy and safety of lenvatinib for the treatment of radioiodine-refractory differentiated thyroid cancer in real-life practice in Russia
    Borodavina, E.
    Isaev, P.
    Shurinov, A.
    Krylov, V.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S1089 - S1090
  • [10] Effectiveness and toxicity of lenvatinib in refractory thyroid cancer: Dutch real-life data
    Aydemirli, M. D.
    Kapiteijn, E.
    Ferrier, K. R. M.
    Ottevanger, P. B.
    Links, T. P.
    van der Horst-Schrivers, A. N. A.
    Broekman, K. E.
    Groenwold, R. H. H.
    Zwaveling, J.
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2020, 182 (02) : 131 - 138
12345